STUDY OF THE IMMUNE DISORDERS IN NONSPECIFIC CHRONIC INFLAMMATORY DISEASES OF THE GENITAL ORGANS
К.І. Davydenko, D.V. Maltsev, Yu.A. Batman, L.V. Natrus
O.O. Bogomolets National Medical University, Kyiv, Ukraine
To study immune disorders: immunograms of 50 adult women
and 41 girls with recurrent non-specific genital inflammations,
were performed in order to characterize the immunodeficiency
in general and justify the treatment correction. The following gynecological examination procedures were performed:
bacterioscopic, bacteriological, cytological and PCR tests,
which didn’t reveal the specific infections. The control group
was represented by 14 women and 14 girls of the same age,
without appropriate complaints, healthy on gynecological
examination. The patients with recurrent non-specific genital
inflammations with the NKT-lymphocytes cytotoxic cells
deficiency made up 65%, those with the immunoglobulin E
(IgE) deficiency – 56%, the group with combined deficiency
of both IgE and Natural Killer T-cell (NKT) – 33%. The IgE
molecule content in morbid girls was almost twice less than
that of the healthy ones, in adult women the IgE deficiency
was 2.5 times less. The decrease in the NKT-lymphocytes in
the group of girls was 4.9 times less compared to the control,
and in healthy women, the decrease made up 1.9 times. The
detected increase of small circulating complexes in blood
plasma, which was observed in 88% of the patients, may be
explained by the manifestations of the immune response to
chronic infection in the genitals. The general immunoassay of
patients with the non-specific genital inflammations showed
the following immune disorder structure: the adaptive immunity humoral component disorder was in almost 70% of
cases, the inborn immunity cellular component was in almost
60% of cases, the adaptive immunity cellular component was
in 28% of cases, complement system disorders were in 26% of
cases, and phagocytosis disorders were in 14% of cases. These
immune disorders may be regarded as the basis of pharmacological correction aimed at covering for the immunodeficiency
and intensification of the affected mucosa immune resistance.
immunodeficiency; IgE; cytotoxic cells; NKTlymphocytes; recurrent inflammation.
1. Stepankivska OV, Shcherbyna MO. Gynecology: a textbook. Ukr Specialized Publ “Medicine”. 2018; ISBN: 978-617-505-543-4. [Ukrainian].
2. Gryshchenko VI, Shcherbina MO, Ventskivskyi BM, et al. Obstetrics and Gynecology: in 2 volumes. Vol 2. Gynecology: textbook / Ukr Specialized Publ “Medicine”. 2022; 3. ISBN: 978-617-505-900-5.
3. Vovk IB, Peterburz’ka VF, Kondratyuk VK. Nonspecific inflammatory diseases of the external genitalia in children and adolescents. Med Aspects Women’s Health. 2015;9: 5-12. [Ukrainian].
4. Magovan BA, Owen P, Thomson A. Clinical obstetrics and gynecology. Ukr Specialized Publ “Medicine”. 2021. ISBN: 978-617-505-882-4. [Ukrainian].
5. Aylamazyan EC, Ryabtseva IT, Yakovlev VG. Gynecology: a textbook for medical schools. St Petersburg: SpetsLit, 2013, 2nd. [Russian].
6. Smith JK, Krishnaswamy GH, Dykes R, et al. Clinical manifestations of IgE hypogammaglobulinemia. Ann Allergy Asthma Immunol. 1997; 78(3):313-8.
7. Bousfiha A, Jeddane L, Picard C, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40,66-81.
8. Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 Update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40:24-64.
9. Roa S, Isidoro-Garcia M, Davila I, Laffond E, Lorente F, Gonzalez-Sarmiento R. Molecular analysis of activationinduced cytidine deaminase gene in immunoglobulin-E deficient patients. Clin Dev Immunol. 2008:146715.
10. Mal’tsev DV, Kazmirchuk VE, Tsaryk VV. Clinic, diagnosis and treatment of isolated IgE deficiency: a review of the literature and a description of clinical cases. Immunol Allergol. 2012;3:5-21. [Ukrainian].
11. Mal’tsev DV, Rybak IR, Horbenko VY. Isolated IgE deficiency in humans: update. Topical Infectol. 2017;1(5):8-14. [Ukrainian].
12. Sutton BJ, Davies AM, Bax HJ, Karagiannis SN. IgE Antibodies: from structure to function and clinical translation. Antibodies (Basel). 2019 Feb 22;8(1):19.
13. Ferastraoaru D, Bax HJ, Bergmann C, et al. AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI). Clin Transl Allergy. 2020;17;10:32.
14. Picado C, de Landazuri IO, Vlagea A, et al. Spectrum of disease manifestations in patients with selective immunoglobulin E deficiency. J Clin Med. 2021; 10(18):4160.
15. McCraw AJ, Chauhan J, Bax HJ, et al. Insights from IgE immune surveillance in allergy and cancer for anti-tumor IgE treatments. Cancers (Basel). 2021;13(17):4460.
16. Okumura A, Ishikawa T, Maeno T, et al. Changes in natural killer T cells subsets during therapy in type C hepatitis and hepatocellular carcinoma. Hepatol Res. 2005;32(4):213-7.
17. Ashkar AA, Rosenthal KL. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol. 2003;77(18):10168-71.
18. Chung BK, Tsai K, Allan LL, et al. Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood. 2013;122(15):2600-08.
19. Montoya CJ, Cataño JC, Ramirez Z, et al. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol. 2008;127(1):1-6.
20. Novakova L, Lehuen A, Novak J. Low numbers and altered phenotype of invariant natural killer T cells in recurrent varicella zoster virus infection. Cell Immunol. 2011;269(2):78-81.
21. Hirna HA, Maltsev DV, Natrus LV, Rozhko MM, Kostyshyn ID, Tanasiychuk IS. Study of the immunomodulating influence of preparation alpha/betadefensins on chemo/radiotherapy of patients with oral and oropharyngeal cancer. Fiziol Zh. 2021; 67(4): 86-96. [Ukrainian]